European Equities Outside the UK: A Guide for Investors in 2026

European equities have been a recurring subject of the "value vs growth" debate in global markets. Continental European companies, particularly in the eurozone, typically trade at meaningful discounts to US equivalents on almost every valuation metric. Whether this discount represents an investment opportunity or simply reflects structural differences in sector composition, corporate governance, and growth prospects is one of the more substantive debates in global equity allocation.

This guide covers the key features of the European ex-UK equity market, the major country and sector exposures, the ASML case study as an example of world-class European competitive advantage, and the practical access options for UK investors.

The Euro Stoxx 50: Composition and Characteristics

The Euro Stoxx 50 is the benchmark index for large-cap eurozone equities, comprising 50 of the largest companies listed in eurozone member states. It is the most widely tracked index for European equity exposure among institutional and retail investors alike.

The index is heavily weighted towards traditional industries:

• Financials (~20%): BNP Paribas, ING, BBVA, Santander, Allianz, AXA
• Consumer discretionary (~15%): LVMH, Hermès, Kering
• Industrials (~12%): Siemens, Schneider Electric, Saint-Gobain, Airbus
• Healthcare (~8%): Sanofi (Novo Nordisk and AstraZeneca are not eurozone-listed and so sit outside the Euro Stoxx 50, appearing only in broader pan-European indices)
• Energy (~6%): TotalEnergies, Eni

Technology is significantly underrepresented compared to the US. ASML, the Dutch semiconductor equipment company, is the standout technology constituent, but the eurozone has no equivalent of the US software mega-caps. This sector composition partly explains the structural valuation discount: financials and industrials historically command lower multiples than software and platform businesses.

Country Composition: Who Dominates?

Within a broader European ex-UK index (such as the MSCI Europe ex-UK or the FTSE Developed Europe ex-UK), country weights vary significantly:

• France (~30–35%): The largest weighting, dominated by luxury goods (LVMH, Hermès, L'Oréal), energy (TotalEnergies), and healthcare (Sanofi). French companies tend to be global market leaders in their niches.
• Germany (~20–25%): Technology (SAP), industrials (Siemens, Infineon), and financials (Allianz, Deutsche Bank). Germany's manufacturing-oriented economy is exposed to global trade cycles and has faced structural headwinds from the energy price shock of 2022.
• Netherlands (~10%): ASML stands out as a world-class technology company; Heineken, Wolters Kluwer, and IMCD round out the Dutch contingent.
• Switzerland (~12–15% in broader European indices, outside eurozone but included in most pan-European mandates): Nestlé, Roche, Novartis, and UBS. Switzerland provides a more defensive, healthcare-oriented tilt and is denominated in CHF, which tends to appreciate in risk-off environments.
• Spain, Italy, Sweden, Denmark (combined ~20%): Banco Santander, Inditex (Zara/Zara Home), Ericsson, Novo Nordisk.

The lack of major technology platform companies (equivalent to Alphabet or Meta) is a structural feature of European markets, not merely a valuation gap. This explains why the "convergence trade" — the argument that European valuations must close the gap with US — is contested.

ASML: A Case Study in European Competitive Advantage

ASML Holding, headquartered in Eindhoven in the Netherlands, occupies one of the most extraordinary competitive positions in global industry: it is the world's sole manufacturer of extreme ultraviolet (EUV) lithography machines, which are essential for producing the most advanced semiconductor chips below 7-nanometre scale.

Every chipmaker — TSMC, Samsung, Intel, SK Hynix — that wants to produce state-of-the-art chips must buy from ASML. There is no alternative supplier. The technology took decades and billions of euros to develop, involving collaboration with government bodies and universities across Europe. The barriers to entry are effectively insurmountable.

EUV machines are priced at approximately €150–200 million each and are shipped in custom Boeing 747 freighters. ASML's order book extends years forward. The company's margins are extraordinary, its growth is tied directly to the global semiconductor investment cycle, and it operates as a near-monopoly in its specific sub-market.

ASML is one of the reasons European equity investors argue the market is underappreciated — world-class companies, often with genuine global monopolies or oligopolies, trading at significant discounts to US equivalents purely due to geography. As of mid-2026, ASML trades at approximately 40–45× forward earnings — a substantial premium to the broader European market, reflecting its near-monopoly position and growth profile.

The European Value Thesis

Eurozone equities typically trade at 13–15× forward earnings versus around 21–22× for the S&P 500. On price-to-book, the discount is even wider: European companies trade at 1.5–2.0× book vs 4–5× for the US.

The bull case for the convergence trade: European companies are undervalued on any fundamental basis; European shareholder return culture is improving (buybacks are increasing); the ECB's rate cycle provides a cleaner backdrop; and capital markets union reform is gradually deepening eurozone financial integration.

The bear case: the valuation discount is structural (different sector mix, weaker technology exposure, regulatory burden, lower population growth); Germany faces energy transition costs and industrial restructuring; political fragmentation in France and Italy creates periodic instability; and European companies have lower return on equity, which justifies lower multiples.

Investors should be sceptical of a simple "cheap therefore buy" argument. The correct question is whether the earnings growth and shareholder returns on offer justify the price, not merely whether the multiple is below the US. For many European companies, particularly in financials, consumer staples, and industrial sectors, the answer is arguably yes.

EUR/GBP Currency Risk for Sterling Investors

European ex-UK equities are predominantly denominated in euros (and, for Swiss holdings, CHF). For a UK investor in sterling, the EUR/GBP exchange rate adds a layer of volatility.

Historically, EUR/GBP has traded in a range of approximately 0.82–0.94. A weaker pound (higher EUR/GBP) increases sterling-denominated returns from European assets. Post-Brexit, sterling has generally been weaker than its pre-2016 range, which has provided a tailwind to UK investors in European assets.

Currency-hedged share classes are available for most major European equity ETFs. The decision to hedge depends on:

• Investment horizon: Over 10+ years, currency effects tend to diminish. For shorter periods, they can dominate.
• Hedging cost: With euro and sterling interest rates closer together than previously, hedging costs are manageable (0.1–0.3% per annum).
• Portfolio context: If you already have significant EUR exposure (European property, business interests), an unhedged European equity holding adds to that concentration.

ECB Policy and the European Macro Context

The European Central Bank began cutting rates in mid-2024 as eurozone inflation returned towards its 2% target. This followed the most aggressive hiking cycle in the ECB's history (2022–2023). Lower interest rates are broadly supportive for equity valuations and for economic growth via cheaper borrowing costs for businesses and consumers.

However, the eurozone faces structural challenges: ageing demographics, energy transition costs, and the competitive challenge from lower-cost manufacturing in Asia. The German economy — the eurozone's largest — has been in or near recession for much of 2023–2025 as it restructures away from Russian energy and faces competition in its core automotive and chemicals sectors.

The EU's Capital Markets Union project — aimed at deepening cross-border financial integration, harmonising insolvency rules, and creating a genuine single market for capital — has made incremental progress but remains incomplete. A more integrated European capital market would reduce the cost of capital for European companies and potentially support higher valuations.

Access: ETFs and Active Funds

UCITS ETFs (London-listed, sterling-tradeable):

• Vanguard FTSE Developed Europe ex-UK UCITS ETF (VERX): TER 0.10%. Tracks the FTSE Developed Europe ex-UK index, covering large and mid caps in 15 European countries.
• iShares Core MSCI Europe UCITS ETF (IMEU): TER 0.12%. Includes UK, providing full European exposure including FTSE 100 companies.
• iShares Core MSCI Europe ex-UK UCITS ETF (IEUX): TER 0.12%. Ex-UK version for investors who want separate UK and European allocations.
• Xtrackers MSCI Europe ex-UK UCITS ETF (XESX): TER 0.12%.

Active managers:

• Fidelity European Fund: Long-running pan-European active fund with quality bias.
• BlackRock Continental European Income: Income-oriented European active fund.
• Jupiter European Focus: High-conviction, concentrated European equity strategy.

Evidence on active management in European equities is more mixed than in the US — some managers have demonstrated persistent alpha, particularly those with bottom-up stock-picking in mid caps. But fees (typically 0.6–0.9%) require clear outperformance to justify versus 0.10–0.12% ETF alternatives.

Risks to Consider

• Structural technology underweight: European indices will likely continue to underperform if AI and software platform companies drive global returns.
• Political risk: French political instability, Italian fiscal concerns, and the ongoing evolution of EU governance create periodic volatility.
• Currency risk: EUR/GBP and CHF/GBP movements affect sterling returns.
• Trade exposure: Major European exporters (auto, chemicals, luxury goods) are exposed to US tariff risk and Chinese demand slowdown.
• Energy transition: German and Dutch industrial companies face significant restructuring costs.

All investments carry the risk of capital loss. Past performance is not a reliable guide to future results. Currency movements can significantly affect returns. This guide is for information only and does not constitute financial advice. Seek professional advice before making investment decisions.

How Global Investments Can Help

Global Investments assists clients in assessing European equity allocations within global portfolios, selecting appropriate indices and fund structures, and deciding on currency hedging strategy. We can help you navigate the distinction between euro-hedged and unhedged exposures and identify where active European managers have added genuine value over time. Contact us to discuss your investment objectives.